What was really striking to me, being a non science person, is the very small difference in the AP between the MCI group and the AD group in Table 1 on page 5 of the first report. If that small of a reduction of AP makes that big of a difference apabetalone could make quite a difference for AD/MCI patients.

Thanks for posting these reports Bear.

tada